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Argyria - Case report*





Abstract: A 70-year-old male rural worker was referred to our clinic with widespread grey pigmentation of the
skin and nails. The condition had been asymptomatic for its entire duration (5 years). He reported past intranasal
application of 10% Silver Vitellinate. A skin biopsy was performed and histology corroborated the clinical diag-
nosis of Argyria. This case represents a currently rare dermatological curiosity. Although silver colloids and salts
have been withdrawn and/or banned by some drug surveillance agencies, they continue to be freely sold and
unregulated as food supplements and as ingredients in alternative medicines, thereby risking the emergence of
new cases of silver poisoning. 
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Resumo: Um homem de 70 anos, trabalhador rural, foi referenciado à nossa consulta por dermatose assintomá-
tica, com 5 anos de evolução, caracterizada pela pigmentação acinzentada generalizada da pele, mais evidente
em áreas fotoexpostas, e das lâminas ungueais. Relatava no passado o uso prolongado de Vitelinato de Prata a
10%, por via nasal. Foi efetuado exame histológico de biopsia cutânea que corroborou o diagnóstico clínico de
Argiria. O caso representa uma curiosidade dermatológica, atualmente rara. Apesar de abandonados e/ou proi-
bidos por algumas instituições de farmacovigilância, a prata coloidal e sais de prata continuam a ser comerciali-
zados como suplementos alimentares, como parte de medicinas alternativas e sem regulação, podendo fazer res-
surgir os casos associados à toxicidade pela prata.
Palavras-chave: Argiria; Compostos de prata; Pigmentação da pele
Received on 09.05.2012.
Approved by the Advisory Board and accepted for publication on 16.06.2012. 
* Study conducted at Santo António dos Capuchos Hospital – Central Lisbon Hospital Center (E.P.E)– Lisbon, Portugal
 Conflict of interest: None
Financial funding: None
1 Bachelor´s Degree in  Medicine – Intern in the Dermatology-Venerology Department - Dermatology Service of the Santo António dos Capuchos Hospital –
Central Lisbon Hospital Center (E.P.E) – Lisbon, Portugal.
2 Bachelor´s Degree in  Medicine – Head of Dermatology Service of the Santo António dos Capuchos Hospital – Central Lisbon Hospital Center (E.P.E) – Lisbon,
Portugal.
3  Bachelor´s Degree in  Medicine – Ad hoc Assistant in the Dermatology Service of the Santo António dos Capuchos Hospital – Central Lisbon Hospital Center
(E.P.E)– Lisbon, Portugal.
©2013 by Anais Brasileiros de Dermatologia
INTRODUCTION
The medicinal use of silver dates back to the
beginning of medical history. Its current routine use as
mainly an antibacterial and antifungal agent in chron-
ic wound care products, medical devices and certain
textiles, calls for a reappraisal of one of its potential
side effects.
Argyria is a rare disease caused by the chronic
absorption of products with a high silver content
which surpass the body´s renal and hepatic excretory
capacities, leading to silver granules being deposited
in the skin and its appendages, mucosae and internal
organs (including the eye, kidney, spleen, bone mar-
row and central nervous system), and causing them to
acquire a blue-grey pigmentation.1 The amount of
absorbed silver required to cause generalized Argyria
pigmentation is unknown. Several different types of
exposure (accidental, therapeutic, occupational and
environmental), routes of administration (oral,
intranasal and percutaneous) and intervals of expo-
sure from 8 months to 5 years have been described.2-6
Skin pigmentation is caused not only by silver
deposition (in sulfite or selenite forms) in the dermis
but also, according to some authors, by the stimula-
tion of melanine synthesis. The reason why the grey
color is more evident on photoexposed skin areas is
unknown. It is believed that silver attains a brownish-
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FIGURE 1: Grey pig-
mentation of the skin,
mainly visible on the
head and photoexpo-
sed areas of the neck
and neckline
FIGURE 3: Histopathological examination of the skin fragment revea-






FIGURE 4: Brown/grey granules in a linear fashion on the basal
membrane of eccrine glands (H&E ´ 400)
black tone through a chemical reduction reaction or
through a photomediated exacerbation of its stimula-
tory effect on melanine synthesis.1
Except in cases involving abrupt absorption of
exaggerated amounts of silver, cases of significant
morbi/mortality are extremely rare. The quantity of
silver present within the bodies of Argyria patients
has no significant effects on health, notwithstanding
cosmetic considerations.6,7 It is generally considered to
be an incurable condition, with no known way of
removing the silver deposits from affected tissues. We
identified an isolated report on the use of Nd:YAG Q-
switched laser which resulted in the skin being
returned to normal  pigmentation.8
CASE REPORT 
A 70-year-old male rural worker, with a part
history of chronic sinusitis and diagnosed with colon
adenocarcinoma around one month prior to our
observation, was referred to us with widespread grey
pigmentation of the skin and nails (Figures 1 and 2).
The condition had been asymptomatic for its entire
duration (5 years). The patient denied the use of
drugs, namely fenotiazines, antimalarials, amio-
darone and mynocicline.
However he reported past intranasal applica-
tion of 10% Silver Vitellinate as a nasal decongestant
and antiseptic. He could provide no details of the
posology or length of application of this drug,
allegedly prescribed by his otolaryngologist. He
denied any other forms of contact with silver in his job
or elsewhere. We observed diffuse grey pigmentation
of the skin (more evident on sun-exposed areas), and
also of the oral and labial mucosae and nail plates.
Blood tests failed to reveal any apparent alter-
ations, namely in electrolytes, or in the metabolism of
iron or copper. Histological examination of a biopsy of
photoexposed truncal skin revealed an unaltered der-
mal and epidermal architecture, deposition of extra-
cellular brownish-grey granules at the dermis, sparing
the epidermis, arranged in clusters or individually, in
a greater amounts at the basal membrane of the
eccrine glands (Figures 3 and 4).
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Bearing in mind the diagnosis of Argyria, the
recent identification of a locally advanced rectum ade-
nocarcinoma, the patient’s age and overall clinical sta-
tus, only measures associated with the aggravating
factors were addressed i.e. to limit the amount of
unprotected sun exposure. The patient declined fur-
ther suggested follow up, having decided that his
main priority was to care for his cancer.
DISCUSSION
In this particular case, identification of the vehi-
cle, exclusion of other concomitant drugs and clinical
and histological tests confirmed the diagnosis of
Argyria.9
Other ingested substances and certain specific
diseases may however produce abnormal cutaneous
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In type II pattern there is blue-







Free coarse deposits or intra-
histiocytic, perivascular or
periadnexal granules.
Hypermelanosis of the basal
cell layer. Hemosiderin gra-
nules within histiocytes and
on the basal membrane of
sweat glands. Perls +*
Perivascular and intrahistio-
cytic granules on the inter-
mediate and upper dermis.
Intrahistiocytic, perivascular
and free superficial granules.
Intrahistiocytic and perivas-
cular pigment. Perls +,
Fontana-Masson +
Perivascular intrahistiocytic
pigment on the intermediate
dermis.
Fontana-Masson +, PAS +,
Ziehl-Neelsen + e Sudan
black +
CHART 1: Main differential diagnoses of Argyria
* - The “+” sign denotes findings highlighted by the stain mentioned.
encountered in Argyria. Substances and diseases that
may induce a grayish-blue tone resulting from pho-
toaggravation include amiodarone, phenotiazines,
criryasis, hemochromatosis. Meanwhile, bisbutya etc
can cause a generalized, uniform effect, while pre-
dominantly  localized reactions can be the result of
ochronosis, mynocicline specific type II pigmentation
pattern, antimalarials and a number of topicals.
Blueish (eventually grayish) pigmentation of the nail
plate may also be observed with antimalarials,
minocycline or gold salts (more rarely).
The pattern of histological alterations induced
by a cutaneous pigmentation agent is sometimes spe-
cific. In this case, the identification of extracellular
clusters of granules disposed in a linear pattern on the
basal membrane of eccrine glands was sufficient to
corroborate the diagnosis of Argyria. (Chart 1).9
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However, except for cases involving heavy met-
als, the skin biopsy may not always allow drug-
induced pigmentation to be distinguished from other
causes which may be equally responsible for an
increase in melanogenesis. If the patient´s clinical his-
tory offers few explanations it might prove worth-
while to measure the metal concentrations in blood,
urine or skin. Electron microscopy, if and when avail-
able, could also be useful.
Although withdrawn (and banned) by some
drug surveillance agencies such as the  FDA, colloidal
silver and/or silver salts are still sold as food supple-
ments, as ingredients in alternative medicines and are
easily available on the Internet and can even be pre-
pared at home. In such circumstances an increase in
cases associated with silver toxicity cannot be ruled
out.3,10
Certain regulated silver-containing materials
are nevertheless still available for medicinal use.
These include dental amalgam, nanocrystalline dress-
ings or silver foams, silver sulfadiazine in cream or
impregnated dressings, silver nitrate pencils and sil-
ver fibers in specialized clothing fabrics. In all these
formulations percutaneous absorption is possible.
While an intact cutaneous barrier is effective against
silver penetration, special attention should however
be paid to products designed to  apply to lesions or
burn areas,  and which can lead to cases of localized or
(more rarely)  systemic Argyria.1,4  ❑
